David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ATVI
Activision Blizzard
ATVI
|
+$757M |
| 2 |
Alibaba
BABA
|
+$544M |
| 3 |
Booking.com
BKNG
|
+$475M |
| 4 |
XLNX
Xilinx Inc
XLNX
|
+$377M |
| 5 |
Caterpillar
CAT
|
+$285M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.07B |
| 2 |
Amazon
AMZN
|
+$486M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$443M |
| 4 |
Salesforce
CRM
|
+$363M |
| 5 |
Qualcomm
QCOM
|
+$352M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 38.33% |
| 2 | Technology | 14.87% |
| 3 | Consumer Discretionary | 9.92% |
| 4 | Healthcare | 7.34% |
| 5 | Financials | 7.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FAZE
3251
DELISTED
FaZe Holdings Inc. Common Stock
FAZE
| $1.28M | ﹤0.01% |
+131,687
| New | +$1.28M |
|
3252
Pliant Therapeutics
PLRX
$71.2M
| $1.28M | ﹤0.01% |
75,994
-13,727
| -15% | -$291K |
|
|
K
3253
PUT
DELISTED
Kellanova
K
| $1.28M | ﹤0.01% |
21,300
-4,793
| -18% | -$287K |
|
3254
Mueller Industries
MLI
$14B
| $1.28M | ﹤0.01% |
124,424
+93,508
| +302% | +$1,000K |
|
|
RAD
3255
PUT
DELISTED
Rite Aid Corporation
RAD
| $1.28M | ﹤0.01% |
90,000
| – | – |
|
3256
PUT
Ascendis Pharma A/S
ASND
$16.3B
| $1.27M | ﹤0.01% |
8,000
| – | – |
|
|
ENVXW
3257
DELISTED
Enovix Corporation Warrant
ENVXW
| $1.27M | ﹤0.01% |
145,901
| – | – |
|
|
CBAY
3258
DELISTED
Cymabay Therapeutics
CBAY
| $1.27M | ﹤0.01% |
348,698
-248,029
| -42% | -$977K |
|
3259
CALL
Hershey
HSY
$36.4B
| $1.27M | ﹤0.01% |
7,500
-25,000
| -77% | -$4.42M |
|
|
PACW
3260
PUT
DELISTED
PacWest Bancorp
PACW
| $1.27M | ﹤0.01% |
28,000
| – | – |
|
3261
Biglari Holdings Class B
BH
$1.22B
| $1.27M | ﹤0.01% |
7,378
-14
| -0.2% | -$2.35K |
|
3262
Liberty Media Series A
FWONA
$23.7B
| $1.27M | ﹤0.01% |
28,108
-31,336
| -53% | -$1.31M |
|
|
REGI
3263
PUT
DELISTED
Renewable Energy Group, Inc.
REGI
| $1.26M | ﹤0.01% |
+25,200
| New | +$1.38M |
|
|
WPRT
3264
Westport Fuel Systems
WPRT
$35.3M
| $1.26M | ﹤0.01% |
38,400
+15,739
| +69% | +$634K |
|
3265
PUT
Herbalife
HLF
$1.31B
| $1.26M | ﹤0.01% |
+29,700
| New | +$1.47M |
|
3266
Madison Square Garden
MSGS
$9.59B
| $1.26M | ﹤0.01% |
6,758
-2,245
| -25% | -$384K |
|
3267
Euronet Worldwide
EEFT
$2.59B
| $1.26M | ﹤0.01% |
9,868
-40,906
| -81% | -$5.43M |
|
3268
McGrath RentCorp
MGRC
$2.77B
| $1.25M | ﹤0.01% |
+17,432
| New | +$1.28M |
|
3269
PUT
EQT Corp
EQT
$33.9B
| $1.25M | ﹤0.01% |
61,200
-2,500
| -4% | -$48.4K |
|
3270
CALL
Centene
CNC
$32.6B
| $1.25M | ﹤0.01% |
20,000
-40,000
| -67% | -$2.67M |
|
|
ZH
3271
Zhihu
ZH
$261M
| $1.24M | ﹤0.01% |
+22,471
| New | +$1.35M |
|
3272
Advanced Energy
AEIS
$11.4B
| $1.24M | ﹤0.01% |
14,167
+6,750
| +91% | +$631K |
|
3273
AngloGold Ashanti
AU
$59.8B
| $1.24M | ﹤0.01% |
77,649
-896,574
| -92% | -$15.5M |
|
3274
NexGen Energy
NXE
$7.47B
| $1.24M | ﹤0.01% |
+261,400
| New | +$1.16M |
|
3275
PUT
Louisiana-Pacific
LPX
$4.98B
| $1.24M | ﹤0.01% |
+20,200
| New | +$1.19M |
|
Similar funds
David Shaw's Q3 2021 Portfolio in Review
As of Q3 2021, David Shaw held 5,618 positions worth $111B, down 4.4% from $116B the previous quarter. Its ten largest holdings account for 9.2% of the portfolio.
David Shaw withdrew a net $13.7B in Q3 2021, closing 695 positions and reducing 1,634 holdings. Its most notable exit was Alexion Pharmaceuticals, an estimated $228M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 38% of assets, up from 35% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, David Shaw opened a new position in Sea Limited worth $206M.
- David Shaw's largest Q3 2021 buy was Sea Limited: 645,697 shares worth $206M.
- David Shaw added most to Activision Blizzard in Q3 2021, an estimated $757M increase.
- David Shaw's biggest Q3 2021 reduction was Apple, cutting an estimated $1.07B.
- David Shaw fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $228M.
- David Shaw's ten largest holdings make up 9.2% of its $111B portfolio in Q3 2021.
- David Shaw opened 915 new positions and closed 695 in Q3 2021.
- David Shaw's portfolio value fell 4.4% quarter-over-quarter to $111B.
Based on D.E. Shaw & Co's 13F filing for Q3 2021, filed 15 Nov 2021.